title: Idelalisib has CLL on the run!
authors.affiliation: DANA-FARBER CANCER INSTITUTE.
authors.forename: Jennifer R
authors.initials: JR
authors.lastname: Brown
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D008297:Male